{"document_text": "Reye syndrome - wikipedia <H1> Reye syndrome </H1> Jump to : navigation , search <Table> <Tr> <Th_colspan=\"2\"> Reye syndrome </Th> </Tr> <Tr> <Th> Synonyms </Th> <Td> Reye 's syndrome </Td> </Tr> <Tr> <Td_colspan=\"2\"> </Td> </Tr> <Tr> <Td_colspan=\"2\"> Appearance of a liver from a child who died of Reye syndrome as seen with a microscope . Hepatocytes are pale - staining due to intracellular fat droplets . </Td> </Tr> <Tr> <Th> Pronunciation </Th> <Td> <Ul> <Li> / ra\u026a \u02c8s\u026andro\u028am / rye SIN - drohm </Li> </Ul> </Td> </Tr> <Tr> <Th> Specialty </Th> <Td> Pediatrics </Td> </Tr> <Tr> <Th> Symptoms </Th> <Td> Vomiting , personality changes , confusion , seizures , loss of consciousness </Td> </Tr> <Tr> <Th> Causes </Th> <Td> Unknown </Td> </Tr> <Tr> <Th> Risk factors </Th> <Td> Aspirin use in children , viral infection </Td> </Tr> <Tr> <Th> Treatment </Th> <Td> Supportive care </Td> </Tr> <Tr> <Th> Medication </Th> <Td> Mannitol </Td> </Tr> <Tr> <Th> Prognosis </Th> <Td> 1 / 3rd long term disability </Td> </Tr> <Tr> <Th> Frequency </Th> <Td> Less than one in a million children a year </Td> </Tr> <Tr> <Th> Deaths </Th> <Td> ~ 30 % chance of death </Td> </Tr> <Tr> <Td_colspan=\"2\"> ( edit on Wikidata ) </Td> </Tr> </Table> <P> Reye syndrome is a rapidly progressive encephalopathy . Symptoms may include vomiting , personality changes , confusion , seizures , and loss of consciousness . Even though liver toxicity typically occurs , yellowish skin usually does not . Death occurs in 20 -- 40 % of those affected and about a third of those who survive are left with a significant degree of brain damage . </P> <P> The cause of Reye syndrome is unknown . It usually begins shortly after recovery from a viral infection , such as influenza or chickenpox . About 90 % of cases are associated with aspirin ( salicylate ) use in children . Inborn errors of metabolism are also a risk factor . Changes on blood tests may include a high blood ammonia level , low blood sugar level , and prolonged prothrombin time . Often the liver is enlarged . </P> <P> Prevention is typically by avoiding the use of aspirin in children . When aspirin was withdrawn for use in children a decrease of more than 90 % in rates of Reye syndrome was seen . Early diagnosis improves outcomes . Treatment is supportive . Mannitol may be used to help with the brain swelling . </P> <P> The first detailed description of Reye syndrome was in 1963 by Douglas Reye . Children are most commonly affected . It affects less than one in a million children a year . The general recommendation to use aspirin in children was withdrawn because of Reye syndrome , with use of aspirin only recommended in Kawasaki disease . </P> <P> </P> <H2> Contents </H2> ( hide ) <Ul> <Li> 1 Signs and symptoms </Li> <Li> 2 Causes <Ul> <Li> 2.1 Aspirin </Li> </Ul> </Li> <Li> 3 Differential diagnosis </Li> <Li> 4 Prognosis </Li> <Li> 5 Epidemiology </Li> <Li> 6 History </Li> <Li> 7 References </Li> <Li> 8 External links </Li> </Ul> <P> </P> <H2> Signs and symptoms ( edit ) </H2> Play media Video explaining Reye syndrome <P> Reye syndrome progresses through five stages : </P> <Ul> <Li> Stage I <Ul> <Li> Rash on palms of hands and feet </Li> <Li> Persistent , heavy vomiting that is not relieved by not eating </Li> <Li> Generalized lethargy </Li> <Li> Confusion </Li> <Li> Nightmares </Li> <Li> No fever usually present </Li> <Li> Headaches </Li> </Ul> </Li> <Li> Stage II <Ul> <Li> Stupor </Li> <Li> Hyperventilation </Li> <Li> Fatty liver ( found by biopsy ) </Li> <Li> Hyperactive reflexes </Li> </Ul> </Li> <Li> Stage III <Ul> <Li> Continuation of Stage I and II symptoms </Li> <Li> Possible coma </Li> <Li> Possible cerebral edema </Li> <Li> Rarely , respiratory arrest </Li> </Ul> </Li> <Li> Stage IV <Ul> <Li> Deepening coma </Li> <Li> Dilated pupils with minimal response to light </Li> <Li> Minimal but still present liver dysfunction </Li> </Ul> </Li> <Li> Stage V <Ul> <Li> Very rapid onset following stage IV </Li> <Li> Deep coma </Li> <Li> Seizures </Li> <Li> Multiple organ failure </Li> <Li> Flaccidity </Li> <Li> Hyperammonemia ( above 300 mg / dL of blood ) </Li> <Li> Death </Li> </Ul> </Li> </Ul> <H2> Causes ( edit ) </H2> <P> The precise mechanism by which Reye syndrome occurs is unknown . This serious condition is described as a `` syndrome '' rather than a disease as the clinical features that physicians use to diagnose it are quite broad . </P> <H3> Aspirin ( edit ) </H3> <P> There is an association between taking aspirin for viral illnesses and the development of Reye syndrome , but no animal model of Reye syndrome has been developed in which aspirin causes the condition . </P> <P> The serious symptoms of Reye syndrome appear to result from damage to cellular mitochondria , at least in the liver , and there are a number of ways that aspirin could cause or exacerbate mitochondrial damage . A potential increased risk of developing Reye syndrome is one of the main reasons that aspirin has not been recommended for use in children and teenagers , the age group for which the risk of lasting serious effects is highest . </P> <P> No research has found a definitive cause of Reye syndrome , and association with aspirin has been shown through epidemiological studies . The diagnosis of `` Reye Syndrome '' greatly decreased in the 1980s , when genetic testing for inborn errors of metabolism was becoming available in developed countries . A retrospective study of 49 survivors of cases diagnosed as `` Reye 's Syndrome '' showed that the majority of the surviving patients had various metabolic disorders , particularly a fatty - acid oxidation disorder medium - chain acyl - CoA dehydrogenase deficiency . </P> <P> In some countries , oral mouthcare product Bonjela ( not the form specifically designed for teething ) has labeling cautioning against its use in children , given its salicylate content . There have been no cases of Reye syndrome following its use , and the measure is a precaution . Other medications containing salicylates are often similarly labeled as a precaution . </P> <P> The Centers for Disease Control and Prevention ( CDC ) , the U.S. Surgeon General , the American Academy of Pediatrics ( AAP ) and the Food and Drug Administration ( FDA ) recommend that aspirin and combination products containing aspirin not be given to children under 19 years of age during episodes of fever - causing illnesses . Hence , in the United States , it is advised that the opinion of a doctor or pharmacist should be obtained before anyone under 19 years of age is given any medication containing aspirin ( also known on some medicine labels as acetylsalicylate , salicylate , acetylsalicylic acid , ASA , or salicylic acid ) . </P> <P> Current advice in the United Kingdom by the Committee on Safety of Medicines is that aspirin should not be given to those under the age of 16 years , unless specifically indicated in Kawasaki disease or in the prevention of blood clot formation . </P> <H2> Differential diagnosis ( edit ) </H2> <P> Causes for similar symptoms include </P> <Ul> <Li> Various inborn metabolic disorders </Li> <Li> Viral encephalitis </Li> <Li> Drug overdose or poisoning </Li> <Li> Head trauma </Li> <Li> Liver failure due to other causes </Li> <Li> Meningitis </Li> <Li> Kidney failure </Li> <Li> Shaken baby syndrome </Li> </Ul> <H2> Prognosis ( edit ) </H2> <P> Documented cases of Reye syndrome in adults are rare . The recovery of adults with the syndrome is generally complete , with liver and brain function returning to normal within two weeks of onset . In children , however , mild to severe permanent brain damage is possible , especially in infants . Over thirty percent of the cases reported in the United States from 1981 through 1997 resulted in fatality . </P> <H2> Epidemiology. ( edit ) </H2> <P> Reye syndrome occurs almost exclusively in children . While a few adult cases have been reported over the years , these cases do not typically show permanent neural or liver damage . Unlike in the UK , the surveillance for Reye syndrome in the US is focused on patients under 18 years of age . </P> <P> In 1980 , after the CDC began cautioning physicians and parents about the association between Reye syndrome and the use of salicylates in children with chickenpox or virus - like illnesses , the incidence of Reye syndrome in the United States began to decline . However , the decline began prior to the FDA 's issue of warning labels on aspirin in 1986 . In the United States between 1980 and 1997 , the number of reported cases of Reye syndrome decreased from 555 cases in 1980 to about 2 cases per year since 1994 . During this time period 93 % of reported cases for which racial data were available occurred in whites and the median age was six years . In 93 % of cases a viral illness had occurred in the preceding three - week period . For the period 1991 - 1994 , the annual rate of hospitalizations due to Reye syndrome in the US was estimated to be between 0.2 and 1.1 per million population less than 18 years of age . </P> <P> During the 1980s , a case - control study carried out in the United Kingdom also demonstrated an association between Reye syndrome and aspirin exposure . In June 1986 , the United Kingdom Committee on Safety of Medicines issued warnings against the use of aspirin in children under 12 years of age and warning labels on aspirin - containing medications were introduced . UK surveillance for Reye syndrome documented a decline in the incidence of the illness after 1986 . The reported incidence rate of Reye syndrome decreased from a high of 0.63 per 100,000 population less than 12 years of age in 1983 / 84 to 0.11 in 1990 / 91 . </P> <P> From November 1995 to November 1996 in France , a national survey of pediatric departments for children under 15 years of age with unexplained encephalopathy and a threefold ( or greater ) increase in serum aminotransferase and / or ammonia led to the identification of nine definite cases of Reye syndrome ( 0.79 cases per million children ) . Eight of the nine children with Reye syndrome were found to have been exposed to aspirin . In part because of this survey result , the French Medicines Agency reinforced the international attention to the relationship between aspirin and Reye syndrome by issuing its own public and professional warnings about this relationship . </P> <H2> History ( edit ) </H2> <P> The syndrome is named after Dr. Douglas Reye , who , along with fellow physicians Drs . Graeme Morgan and Jim Baral , published the first study of the syndrome in 1963 in The Lancet . In retrospect , the occurrence of the syndrome may have first been reported in 1929 . Also in 1964 , Dr. George Johnson and colleagues published an investigation of an outbreak of influenza B that described 16 children who developed neurological problems , four of whom had a profile remarkably similar to Reye syndrome . Some investigators refer to this disorder as Reye - Johnson syndrome , although it is more commonly called Reye syndrome . In 1979 , Dr. Karen Starko and colleagues conducted a case - control study in Phoenix , Arizona and found the first statistically - significant link between aspirin use and Reye syndrome . Studies in Ohio and Michigan soon confirmed her findings pointing to the use of aspirin during an upper respiratory tract or chickenpox infection as a possible trigger of the syndrome . Beginning in 1980 , the CDC cautioned physicians and parents about the association between Reye syndrome and the use of salicylates in children and teenagers with chickenpox or virus - like illnesses . In 1982 the U.S. Surgeon General issued an advisory , and in 1986 the Food and Drug Administration required a Reye syndrome - related warning label for all aspirin - containing medications . </P> <H2> References ( edit ) </H2> <Ol> <Li> ^ Jump up to : `` NINDS Reye 's Syndrome Information Page '' . NINDS . September 25 , 2009 . Archived from the original on August 1 , 2016 . Retrieved August 8 , 2016 . </Li> <Li> ^ Jump up to : Pugliese , A ; Beltramo , T ; Torre , D ( October 2008 ) . `` Reye 's and Reye 's - like syndromes . '' . Cell biochemistry and function . 26 ( 7 ) : 741 -- 6 . PMID 18711704 . doi : 10.1002 / cbf. 1465 . </Li> <Li> ^ Jump up to : Schr\u00f6r , K ( 2007 ) . `` Aspirin and Reye syndrome : a review of the evidence . '' . Paediatric drugs . 9 ( 3 ) : 195 -- 204 . PMID 17523700 . doi : 10.2165 / 00148581 - 200709030 - 00008 . </Li> <Li> Jump up ^ McMillan , Julia A. ; Feigin , Ralph D. ; DeAngelis , Catherine ; Jones , M. Douglas ( 2006 ) . Oski 's Pediatrics : Principles & Practice . Philadelphia : Lippincott Williams & Wilkins . p. 2306 . ISBN 9780781738941 . Archived from the original on August 15 , 2016 . </Li> <Li> Jump up ^ Knight , J. ( 2009 ) . `` Reye 's Syndrome '' . Healthy Child Care . 12 ( 4 ) . Archived from the original on May 22 , 2013 . </Li> <Li> Jump up ^ Boldt , D.W. ( February 2003 ) . `` Reye Syndrome '' . University of Hawaii John A. Burns School of Medicine . Archived from the original on March 6 , 2013 . </Li> <Li> Jump up ^ `` What is Reye 's Syndrome ? '' . National Reye 's Syndrome Foundation . Archived from the original on May 11 , 2013 . </Li> <Li> Jump up ^ `` Reye 's Syndrome '' . KidsHealth.org . Nemour Foundation . Archived from the original on February 6 , 2015 . Retrieved February 6 , 2015 . </Li> <Li> Jump up ^ Ku AS , Chan LT ( April 1999 ) . `` The first case of H5N1 avian influenza infection in a human with complications of adult respiratory distress syndrome and Reye 's syndrome '' . Journal of Paediatrics and Child Health . 35 ( 2 ) : 207 -- 9 . PMID 10365363 . doi : 10.1046 / j. 1440 - 1754.1999. t01 - 1 - 00329. x . </Li> <Li> Jump up ^ Hurwitz , E.S. ( 1989 ) . `` Reye 's syndrome '' . Epidemiologic reviews . 11 : 249 -- 253 . PMID 2680560 . </Li> <Li> ^ Jump up to : Orlowski JP , Hanhan UA , Fiallos MR ( 2002 ) . `` Is aspirin a cause of Reye 's syndrome ? A case against '' . Drug Safety . 25 ( 4 ) : 225 -- 31 . PMID 11994026 . doi : 10.2165 / 00002018 - 200225040 - 00001 . Archived from the original on October 23 , 2012 . </Li> <Li> Jump up ^ Gosalakkal JA , Kamoji V ( September 2008 ) . `` Reye syndrome and reye - like syndrome '' . Pediatric Neurology . 39 ( 3 ) : 198 -- 200 . PMID 18725066 . doi : 10.1016 / j. pediatrneurol. 2008.06. 003 . </Li> <Li> Jump up ^ Orlowski JP ( August 1999 ) . `` Whatever happened to Reye 's syndrome ? Did it ever really exist ? '' . Critical Care Medicine . 27 ( 8 ) : 1582 -- 7 . PMID 10470768 . doi : 10.1097 / 00003246 - 199908000 - 00032 . </Li> <Li> Jump up ^ `` New advice on oral salicylate gels in under 16s '' ( Press release ) . Medicines and Healthcare products Regulatory Agency . April 23 , 2009 . Archived from the original on April 26 , 2009 . Retrieved May 1 , 2009 . </Li> <Li> Jump up ^ `` 2.9 Antiplatelet drugs '' . British National Formulary for Children . British Medical Association and Royal Pharmaceutical Society of Great Britain . 2007 . p. 151 . </Li> <Li> Jump up ^ Hall SM , Plaster PA , Glasgow JF , Hancock P ( 1988 ) . `` Preadmission antipyretics in Reye 's syndrome '' . Arch . Dis . Child . 63 ( 7 ) : 857 -- 66 . PMC 1779086 . PMID 3415311 . doi : 10.1136 / adc. 63.7. 857 . </Li> <Li> Jump up ^ Autret - Leca E , Jonville - B\u00e9ra AP , Llau ME , et al. ( 2001 ) . `` Incidence of Reye 's syndrome in France : a hospital - based survey '' . Journal of Clinical Epidemiology. 54 ( 8 ) : 857 -- 62 . PMID 11470397 . doi : 10.1016 / S0895 - 4356 ( 00 ) 00366 - 8 . </Li> <Li> Jump up ^ Reye RD , Morgan G , Baral J ( 1963 ) . `` Encephalopathy and fatty degeneration of the viscera . A Disease entity in childhood '' . Lancet . 2 ( 7311 ) : 749 -- 52 . PMID 14055046 . doi : 10.1016 / S0140 - 6736 ( 63 ) 90554 - 3 . </Li> <Li> Jump up ^ Starko KM , Ray CG , Dominguez LB , Stromberg WL , Woodall DF ( December 1980 ) . `` Reye 's syndrome and salicylate use '' . Pediatrics. 66 ( 6 ) : 859 -- 864 . PMID 7454476 . </Li> <Li> Jump up ^ Mortimor , Edward A. , Jr. ; et al. ( June 1 , 1980 ) . `` Reye Syndrome - Ohio , Michigan '' . Morbidity and Mortality Weekly Report . 69 ( 29 ) : 532 , 810 -- 2 . PMID 7079050 . Archived from the original on June 11 , 2008 . </Li> <Li> Jump up ^ Associated Press ( March 8 , 1986 ) . `` Aspirin Labels to Warn About Reye Syndrome '' . The New York Times . Archived from the original on March 5 , 2016 . </Li> </Ol> <H2> External links ( edit ) </H2> <Table> <Tr> <Th> Classification </Th> <Td> V T D <Ul> <Li> ICD - 10 : G93. 7 </Li> <Li> ICD - 9 - CM : 331.81 </Li> <Li> MeSH : D012202 </Li> <Li> DiseasesDB : 11463 </Li> </Ul> </Td> </Tr> <Tr> <Th> External resources </Th> <Td> <Ul> <Li> MedlinePlus : 001565 </Li> <Li> eMedicine : emerg / 399 </Li> <Li> Patient UK : Reye syndrome </Li> <Li> Orphanet : 3096 </Li> </Ul> </Td> </Tr> </Table> <P> </P> <Ul> <Li> NINDS Reye 's Syndrome Information Page </Li> </Ul> <Table> <Tr> <Th_colspan=\"2\"> ( hide ) <Ul> <Li> </Li> <Li> </Li> <Li> </Li> </Ul> Diseases of the nervous system , primarily CNS ( G04 -- G47 , 323 -- 349 ) </Th> </Tr> <Tr> <Th> Inflammation </Th> <Td> <Table> <Tr> <Th> Brain </Th> <Td> <Ul> <Li> Encephalitis <Ul> <Li> Viral encephalitis </Li> <Li> Herpesviral encephalitis </Li> <Li> Limbic encephalitis </Li> <Li> Encephalitis lethargica </Li> </Ul> </Li> <Li> Cavernous sinus thrombosis </Li> <Li> Brain abscess <Ul> <Li> Amoebic </Li> </Ul> </Li> </Ul> </Td> </Tr> <Tr> <Th> Spinal cord </Th> <Td> <Ul> <Li> Myelitis : Poliomyelitis </Li> <Li> Demyelinating disease <Ul> <Li> Transverse myelitis </Li> </Ul> </Li> <Li> Tropical spastic paraparesis </Li> <Li> Epidural abscess </Li> </Ul> </Td> </Tr> <Tr> <Th> Both / either </Th> <Td> <Ul> <Li> Encephalomyelitis <Ul> <Li> Acute disseminated </Li> <Li> Myalgic </Li> </Ul> </Li> <Li> Meningoencephalitis </Li> </Ul> </Td> </Tr> </Table> </Td> </Tr> <Tr> <Th> Brain / encephalopathy </Th> <Td> <Table> <Tr> <Th> Degenerative </Th> <Td> <Table> <Tr> <Th> Extrapyramidal and movement disorders </Th> <Td> <Ul> <Li> Basal ganglia disease <Ul> <Li> Parkinsonism <Ul> <Li> PD </Li> <Li> Postencephalitic </Li> <Li> NMS </Li> </Ul> </Li> <Li> PKAN </Li> <Li> Tauopathy <Ul> <Li> PSP </Li> </Ul> </Li> <Li> Striatonigral degeneration </Li> <Li> Hemiballismus </Li> <Li> HD </Li> <Li> OA </Li> </Ul> </Li> </Ul> <Ul> <Li> Dyskinesia <Ul> <Li> Dystonia <Ul> <Li> Status dystonicus </Li> <Li> Spasmodic torticollis </Li> <Li> Meige 's </Li> <Li> Blepharospasm </Li> </Ul> </Li> <Li> Athetosis </Li> <Li> Chorea <Ul> <Li> Choreoathetosis </Li> </Ul> </Li> <Li> Myoclonus <Ul> <Li> Myoclonic epilepsy </Li> </Ul> </Li> <Li> Akathisia </Li> </Ul> </Li> </Ul> <Ul> <Li> Tremor <Ul> <Li> Essential tremor </Li> <Li> Intention tremor </Li> </Ul> </Li> <Li> Restless legs </Li> <Li> Stiff person </Li> </Ul> </Td> </Tr> <Tr> <Th> Dementia </Th> <Td> <Ul> <Li> Tauopathy <Ul> <Li> Alzheimer 's <Ul> <Li> Early - onset </Li> </Ul> </Li> <Li> Primary progressive aphasia </Li> </Ul> </Li> <Li> Frontotemporal dementia / Frontotemporal lobar degeneration <Ul> <Li> Pick 's </Li> <Li> Dementia with Lewy bodies </Li> </Ul> </Li> <Li> Posterior cortical atrophy </Li> </Ul> <Ul> <Li> Vascular dementia </Li> </Ul> </Td> </Tr> <Tr> <Th> Mitochondrial disease </Th> <Td> <Ul> <Li> Leigh disease </Li> </Ul> </Td> </Tr> </Table> </Td> </Tr> <Tr> <Th> Demyelinating </Th> <Td> <Ul> <Li> autoimmune <Ul> <Li> Multiple sclerosis </Li> <Li> Neuromyelitis optica </Li> <Li> Schilder 's disease </Li> </Ul> </Li> <Li> hereditary <Ul> <Li> Adrenoleukodystrophy </Li> <Li> Alexander </Li> <Li> Canavan </Li> <Li> Krabbe </Li> <Li> ML </Li> <Li> PMD </Li> <Li> VWM </Li> <Li> MFC </Li> <Li> CAMFAK syndrome </Li> </Ul> </Li> <Li> Central pontine myelinolysis </Li> <Li> Marchiafava -- Bignami disease </Li> <Li> Alpers ' disease </Li> </Ul> </Td> </Tr> <Tr> <Th> Episodic / paroxysmal </Th> <Td> <Table> <Tr> <Th> Seizure / epilepsy </Th> <Td> <Ul> <Li> Focal </Li> <Li> Generalised </Li> <Li> Status epilepticus </Li> <Li> Myoclonic epilepsy </Li> </Ul> </Td> </Tr> <Tr> <Th> Headache </Th> <Td> <Ul> <Li> Migraine <Ul> <Li> Familial hemiplegic </Li> </Ul> </Li> <Li> Cluster </Li> <Li> Tension </Li> </Ul> </Td> </Tr> <Tr> <Th> Cerebrovascular </Th> <Td> <Ul> <Li> TIA <Ul> <Li> Amaurosis fugax </Li> <Li> Transient global amnesia </Li> <Li> Acute aphasia </Li> </Ul> </Li> </Ul> <Ul> <Li> Stroke <Ul> <Li> MCA </Li> <Li> ACA </Li> <Li> PCA </Li> <Li> Foville 's </Li> <Li> Millard -- Gubler </Li> <Li> Lateral medullary </Li> <Li> Weber 's </Li> <Li> Lacunar stroke </Li> </Ul> </Li> </Ul> </Td> </Tr> <Tr> <Th> Sleep disorders </Th> <Td> <Ul> <Li> Insomnia </Li> <Li> Hypersomnia </Li> <Li> Sleep apnea <Ul> <Li> Obstructive </Li> <Li> Congenital central hypoventilation syndrome </Li> </Ul> </Li> <Li> Narcolepsy </Li> <Li> Cataplexy </Li> <Li> Kleine -- Levin </Li> <Li> Circadian rhythm sleep disorder <Ul> <Li> Advanced sleep phase disorder </Li> <Li> Delayed sleep phase disorder </Li> <Li> Non-24 - hour sleep -- wake disorder </Li> <Li> Jet lag </Li> </Ul> </Li> </Ul> </Td> </Tr> </Table> </Td> </Tr> <Tr> <Th> CSF </Th> <Td> <Ul> <Li> Intracranial hypertension <Ul> <Li> Hydrocephalus / NPH </Li> <Li> Choroid plexus papilloma </Li> <Li> Idiopathic intracranial hypertension </Li> </Ul> </Li> <Li> Cerebral edema </Li> <Li> Intracranial hypotension </Li> </Ul> </Td> </Tr> <Tr> <Th> Other </Th> <Td> <Ul> <Li> Brain herniation </Li> <Li> Reye 's </Li> <Li> Hepatic encephalopathy </Li> <Li> Toxic encephalopathy </Li> <Li> Hashimoto 's encephalopathy </Li> </Ul> </Td> </Tr> </Table> </Td> </Tr> <Tr> <Th> Spinal cord / myelopathy </Th> <Td> <Ul> <Li> Syringomyelia </Li> <Li> Syringobulbia </Li> <Li> Morvan 's syndrome </Li> <Li> Vascular myelopathy <Ul> <Li> Foix -- Alajouanine syndrome </Li> </Ul> </Li> <Li> Spinal cord compression </Li> </Ul> </Td> </Tr> <Tr> <Th> Both / either </Th> <Td> <Table> <Tr> <Th> Degenerative </Th> <Td> <Table> <Tr> <Th> SA </Th> <Td> <Ul> <Li> Friedreich 's ataxia </Li> <Li> Ataxia - telangiectasia </Li> </Ul> </Td> </Tr> <Tr> <Th> MND </Th> <Td> <Ul> <Li> UMN only : <Ul> <Li> Primary lateral sclerosis </Li> <Li> Pseudobulbar palsy </Li> <Li> Hereditary spastic paraplegia </Li> </Ul> </Li> </Ul> <Ul> <Li> LMN only : <Ul> <Li> Distal hereditary motor neuronopathies </Li> <Li> Spinal muscular atrophies <Ul> <Li> SMA </Li> <Li> SMAX1 </Li> <Li> SMAX2 </Li> <Li> DSMA1 </Li> <Li> Congenital DSMA </Li> <Li> SMA - PCH </Li> <Li> SMA - LED </Li> <Li> SMA - PME </Li> </Ul> </Li> <Li> Progressive muscular atrophy </Li> <Li> Progressive bulbar palsy <Ul> <Li> Fazio -- Londe </Li> <Li> Infantile progressive bulbar palsy </Li> </Ul> </Li> </Ul> </Li> </Ul> <Ul> <Li> both : <Ul> <Li> Amyotrophic lateral sclerosis </Li> </Ul> </Li> </Ul> </Td> </Tr> </Table> </Td> </Tr> </Table> </Td> </Tr> </Table> <Table> <Tr> <Th> </Th> <Td> <Ul> <Li> NDL : 00576410 </Li> </Ul> </Td> </Tr> </Table> Retrieved from `` https://REMOVED_SECRET/w/index.php?title=Reye_syndrome&oldid=806293414 '' Categories : <Ul> <Li> Pediatrics </Li> <Li> Toxicology </Li> <Li> Hepatology </Li> <Li> Syndromes </Li> <Li> Ailments of unknown cause </Li> </Ul> Hidden categories : <Ul> <Li> Use mdy dates from May 2017 </Li> <Li> All articles with unsourced statements </Li> <Li> Articles with unsourced statements from March 2015 </Li> <Li> Articles with unsourced statements from August 2015 </Li> <Li> RTT </Li> <Li> RTTNEURO </Li> </Ul> <H2> </H2> <H3> </H3> <Ul> <Li> </Li> <Li> Talk </Li> <Li> </Li> <Li> </Li> <Li> </Li> </Ul> <H3> </H3> <Ul> <Li> </Li> <Li> </Li> </Ul> <H3> </H3> <Ul> </Ul> <H3> </H3> <Ul> <Li> </Li> <Li> </Li> <Li> </Li> </Ul> <H3> </H3> <Ul> </Ul> <H3> </H3> <H3> </H3> <Ul> <Li> </Li> <Li> Contents </Li> <Li> </Li> <Li> </Li> <Li> </Li> <Li> </Li> <Li> </Li> </Ul> <H3> </H3> <Ul> <Li> </Li> <Li> About Wikipedia </Li> <Li> </Li> <Li> </Li> <Li> </Li> </Ul> <H3> </H3> <Ul> <Li> </Li> <Li> </Li> <Li> </Li> <Li> </Li> <Li> </Li> <Li> </Li> <Li> </Li> <Li> </Li> </Ul> <H3> </H3> <Ul> <Li> </Li> <Li> </Li> <Li> </Li> </Ul> <H3> </H3> <Ul> <Li> </Li> </Ul> <H3> </H3> <Ul> <Li> </Li> <Li> \u0411\u0435\u043b\u0430\u0440\u0443\u0441\u043a\u0430\u044f </Li> <Li> Bosanski </Li> <Li> Catal\u00e0 </Li> <Li> \u010ce\u0161tina </Li> <Li> Deutsch </Li> <Li> Espa\u00f1ol </Li> <Li> \u0641\u0627\u0631\u0633\u06cc </Li> <Li> Fran\u00e7ais </Li> <Li> Gaeilge </Li> <Li> Galego </Li> <Li> \ud55c\uad6d\uc5b4 </Li> <Li> \u0540\u0561\u0575\u0565\u0580\u0565\u0576 </Li> <Li> Hrvatski </Li> <Li> Italiano </Li> <Li> Magyar </Li> <Li> \u041c\u0430\u043a\u0435\u0434\u043e\u043d\u0441\u043a\u0438 </Li> <Li> Nederlands </Li> <Li> \u65e5\u672c \u8a9e </Li> <Li> \u0b13\u0b21\u0b3c\u0b3f\u0b06 </Li> <Li> Polski </Li> <Li> Portugu\u00eas </Li> <Li> Rom\u00e2n\u0103 </Li> <Li> \u0420\u0443\u0441\u0441\u043a\u0438\u0439 </Li> <Li> Simple English </Li> <Li> Sloven\u0161\u010dina </Li> <Li> \u0421\u0440\u043f\u0441\u043a\u0438 / srpski </Li> <Li> Srpskohrvatski / \u0441\u0440\u043f\u0441\u043a\u043e\u0445\u0440\u0432\u0430\u0442\u0441\u043a\u0438 </Li> <Li> Suomi </Li> <Li> Svenska </Li> <Li> \u0ba4\u0bae\u0bbf\u0bb4\u0bcd </Li> <Li> \u0e44\u0e17\u0e22 </Li> <Li> T\u00fcrk\u00e7e </Li> <Li> \u0423\u043a\u0440\u0430\u0457\u043d\u0441\u044c\u043a\u0430 </Li> <Li> Ti\u1ebfng Vi\u1ec7t </Li> <Li> \u7cb5\u8a9e </Li> <Li> \u4e2d\u6587 </Li> </Ul> Edit links <Ul> <Li> This page was last edited on 21 October 2017 , at 01 : 06 . </Li> <Li> Text is available under the Creative Commons Attribution - ShareAlike License ; additional terms may apply . By using this site , you agree to the Terms of Use and Privacy Policy . Wikipedia \u00ae is a registered trademark of the Wikimedia Foundation , Inc. , a non-profit organization . </Li> </Ul> <Ul> <Li> </Li> <Li> About Wikipedia </Li> <Li> </Li> <Li> </Li> <Li> </Li> <Li> </Li> <Li> </Li> <Li> </Li> </Ul> <Ul> <Li> </Li> <Li> </Li> </Ul>", "long_answer_candidates": [{"start_token": 14, "top_level": true, "end_token": 206}, {"start_token": 15, "top_level": false, "end_token": 21}, {"start_token": 21, "top_level": false, "end_token": 31}, {"start_token": 35, "top_level": false, "end_token": 68}, {"start_token": 68, "top_level": false, "end_token": 87}, {"start_token": 73, "top_level": false, "end_token": 85}, {"start_token": 74, "top_level": false, "end_token": 84}, {"start_token": 87, "top_level": false, "end_token": 95}, {"start_token": 95, "top_level": false, "end_token": 114}, {"start_token": 114, "top_level": false, "end_token": 122}, {"start_token": 122, "top_level": false, "end_token": 137}, {"start_token": 137, "top_level": false, "end_token": 146}, {"start_token": 146, "top_level": false, "end_token": 154}, {"start_token": 154, "top_level": false, "end_token": 167}, {"start_token": 167, "top_level": false, "end_token": 183}, {"start_token": 183, "top_level": false, "end_token": 196}, {"start_token": 196, "top_level": false, "end_token": 205}, {"start_token": 206, "top_level": true, "end_token": 274}, {"start_token": 274, "top_level": true, "end_token": 355}, {"start_token": 355, "top_level": true, "end_token": 412}, {"start_token": 412, "top_level": true, "end_token": 471}, {"start_token": 539, "top_level": true, "end_token": 548}, {"start_token": 548, "top_level": true, "end_token": 723}, {"start_token": 549, "top_level": false, "end_token": 596}, {"start_token": 552, "top_level": false, "end_token": 595}, {"start_token": 553, "top_level": false, "end_token": 562}, {"start_token": 562, "top_level": false, "end_token": 575}, {"start_token": 585, "top_level": false, "end_token": 591}, {"start_token": 596, "top_level": false, "end_token": 621}, {"start_token": 599, "top_level": false, "end_token": 620}, {"start_token": 606, "top_level": false, "end_token": 615}, {"start_token": 621, "top_level": false, "end_token": 651}, {"start_token": 624, "top_level": false, "end_token": 650}, {"start_token": 625, "top_level": false, "end_token": 634}, {"start_token": 638, "top_level": false, "end_token": 643}, {"start_token": 643, "top_level": false, "end_token": 649}, {"start_token": 651, "top_level": false, "end_token": 678}, {"start_token": 654, "top_level": false, "end_token": 677}, {"start_token": 659, "top_level": false, "end_token": 668}, {"start_token": 668, "top_level": false, "end_token": 676}, {"start_token": 678, "top_level": false, "end_token": 722}, {"start_token": 681, "top_level": false, "end_token": 721}, {"start_token": 682, "top_level": false, "end_token": 690}, {"start_token": 697, "top_level": false, "end_token": 702}, {"start_token": 705, "top_level": false, "end_token": 717}, {"start_token": 729, "top_level": true, "end_token": 770}, {"start_token": 776, "top_level": true, "end_token": 812}, {"start_token": 812, "top_level": true, "end_token": 892}, {"start_token": 892, "top_level": true, "end_token": 988}, {"start_token": 988, "top_level": true, "end_token": 1052}, {"start_token": 1052, "top_level": true, "end_token": 1169}, {"start_token": 1169, "top_level": true, "end_token": 1215}, {"start_token": 1222, "top_level": true, "end_token": 1229}, {"start_token": 1229, "top_level": true, "end_token": 1271}, {"start_token": 1230, "top_level": false, "end_token": 1236}, {"start_token": 1240, "top_level": false, "end_token": 1246}, {"start_token": 1250, "top_level": false, "end_token": 1258}, {"start_token": 1265, "top_level": false, "end_token": 1270}, {"start_token": 1277, "top_level": true, "end_token": 1351}, {"start_token": 1357, "top_level": true, "end_token": 1414}, {"start_token": 1414, "top_level": true, "end_token": 1593}, {"start_token": 1593, "top_level": true, "end_token": 1708}, {"start_token": 1708, "top_level": true, "end_token": 1822}, {"start_token": 1828, "top_level": true, "end_token": 2072}], "question_text": "an idiopathic condition associated with asprin treatment during certain viral infections", "annotations": [{"yes_no_answer": "NONE", "long_answer": {"start_token": 274, "candidate_index": 18, "end_token": 355}, "short_answers": [{"start_token": 278, "end_token": 280}], "annotation_id": 4266195496040862890}], "document_url": "https://REMOVED_SECRET//w/index.php?title=Reye_syndrome&amp;oldid=806293414", "example_id": -4338100494146837657}